These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25022269)

  • 1. Isotretinoin use and celiac disease: a population-based cross-sectional study.
    Lebwohl B; Sundström A; Jabri B; Kupfer SS; Green PH; Ludvigsson JF
    Am J Clin Dermatol; 2014 Dec; 15(6):537-42. PubMed ID: 25022269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isotretinoin and risk of inflammatory bowel disease: a French nationwide study.
    Racine A; Cuerq A; Bijon A; Ricordeau P; Weill A; Allemand H; Chosidow O; Boutron-Ruault MC; Carbonnel F
    Am J Gastroenterol; 2014 Apr; 109(4):563-9. PubMed ID: 24535094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotretinoin Exposure and Risk of Celiac Disease.
    Rashtak S; Khaleghi S; Marietta EV; Pittelkow MR; Larson JJ; Lahr BD; Murray JA
    PLoS One; 2015; 10(8):e0135881. PubMed ID: 26287738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotretinoin use and the risk of inflammatory bowel disease: a case-control study.
    Crockett SD; Porter CQ; Martin CF; Sandler RS; Kappelman MD
    Am J Gastroenterol; 2010 Sep; 105(9):1986-93. PubMed ID: 20354506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observational retrospective study evaluating the effects of oral isotretinoin in keloids and hypertrophic scars.
    Guadanhim LR; Gonçalves RG; Bagatin E
    Int J Dermatol; 2016 Nov; 55(11):1255-1258. PubMed ID: 27419807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data.
    Etminan M; Bird ST; Delaney JA; Bressler B; Brophy JM
    JAMA Dermatol; 2013 Feb; 149(2):216-20. PubMed ID: 23426479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
    Azoulay L; Oraichi D; Bérard A
    Br J Dermatol; 2007 Dec; 157(6):1240-8. PubMed ID: 17970803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acne with oral isotretinoin in patients with cystic fibrosis.
    Perera E; Massie J; Phillips RJ
    Arch Dis Child; 2009 Aug; 94(8):583-6. PubMed ID: 19465582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dietary supplement to reduce side effects of oral isotretinoin therapy in acne patients.
    Fabbrocini G; Cameli N; Lorenzi S; De Padova MP; Marasca C; Izzo R; Monfrecola G
    G Ital Dermatol Venereol; 2014 Aug; 149(4):441-5. PubMed ID: 25068233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does hemochromatosis predispose to celiac disease? A study of 29,096 celiac disease patients.
    Ludvigsson JF; Murray JA; Adams PC; Elmberg M
    Scand J Gastroenterol; 2013 Feb; 48(2):176-82. PubMed ID: 23256862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turner Syndrome and Celiac Disease: A Case-Control Study.
    Mårild K; Størdal K; Hagman A; Ludvigsson JF
    Pediatrics; 2016 Feb; 137(2):e20152232. PubMed ID: 26746404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of clinical adverse effects and laboratory alterations in patients with acne vulgaris treated with oral isotretinoin.
    Brito Mde F; Sant'Anna IP; Galindo JC; Rosendo LH; Santos JB
    An Bras Dermatol; 2010; 85(3):331-7. PubMed ID: 20676466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study.
    Alhusayen RO; Juurlink DN; Mamdani MM; Morrow RL; Shear NH; Dormuth CR;
    J Invest Dermatol; 2013 Apr; 133(4):907-12. PubMed ID: 23096714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study.
    Sundström A; Alfredsson L; Sjölin-Forsberg G; Gerdén B; Bergman U; Jokinen J
    BMJ; 2010 Nov; 341():c5812. PubMed ID: 21071484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin.
    Baykal Selçuk L; Aksu Arıca D; Baykal Şahin H; Yaylı S; Bahadır S
    Cutan Ocul Toxicol; 2017 Jun; 36(2):176-179. PubMed ID: 27764978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public Understanding and Awareness of Isotretinoin Use and Safety in Al Ahsa, Eastern Saudi Arabia.
    Younis NS; Al-Harbi NY
    Ther Innov Regul Sci; 2019 Sep; 53(5):618-622. PubMed ID: 30380941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celiac Disease and Risk of Henoch-Schonlein Purpura: Population-based Cohort Study.
    Ludvigsson JF; Jarrick S; Murray JA; Emilsson L
    J Clin Gastroenterol; 2018 Feb; 52(2):141-145. PubMed ID: 27820222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and adverse events of oral isotretinoin for acne: a systematic review.
    Vallerand IA; Lewinson RT; Farris MS; Sibley CD; Ramien ML; Bulloch AGM; Patten SB
    Br J Dermatol; 2018 Jan; 178(1):76-85. PubMed ID: 28542914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin.
    Rademaker M
    Australas J Dermatol; 2010 Nov; 51(4):248-53. PubMed ID: 21198520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
    Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
    JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.